Injectable tirzepatide demonstrated 16-22.5% weight loss over 72 weeks in the SURMOUNT trials
Others using vials, either compounded or branded, may draw up custom doses with a syringe
Alexandra Sowa, a New York-based internal medicine and obesity expert, in her book The Ozempic Revolution (2025), one of the first comprehensive, experience-based guides to a fulfilling GLP-1 journey: You need to know how to thrive
Cardiometabolic Markers: Both drugs dramatically improve key indicators
Moreover, GLP-1 triggers a change in conformation of its receptor, leading to the activation of a Gs protein and the production of secondary messengers
Individuals who need a medication that supports gradual and sustainable weight loss